Tu carrito está vacío
Empieza a añadir péptidos de investigación a tu carrito.
TAMBIÉN TE PUEDE INTERESAR
A first-in-class dual GIP/GLP-1 receptor agonist peptide with superior metabolic efficacy, acting on both incretin pathways simultaneously.
Tirzepatide is a 39-amino acid synthetic peptide and the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, representing a paradigm shift in metabolic peptide research. Its structure is based on the native GIP sequence with modifications that enable cross-reactivity at the GLP-1 receptor, combined with a C20 fatty diacid moiety for albumin binding that extends its half-life to approximately 5 days. Tirzepatide demonstrates biased agonism at the GIP receptor, meaning it preferentially activates certain intracellular signalling cascades over others, which is believed to contribute to its enhanced efficacy. In major clinical trials (SURPASS and SURMOUNT programmes), tirzepatide achieved unprecedented reductions in body weight and glycated haemoglobin. ORYN offers tirzepatide in both the standard Peptide Pen (10 mg) and MediT Pen (40 mg prefilled weekly) formats.
Glucagon-Like Peptide-1, an incretin hormone that regulates blood sugar, slows gastric emptying, and reduces appetite, targeted by semaglutide and tirzepatide.
Glucose-dependent Insulinotropic Polypeptide receptor, a key target in metabolic peptide research that mediates insulin secretion and energy homeostasis.
A long-acting GLP-1 receptor agonist peptide used in metabolic research, with a modified structure that extends its half-life to approximately one week.
A molecule that binds to and activates a cellular receptor, mimicking or enhancing the effect of the natural signalling molecule (ligand).
The fundamental building blocks of peptides and proteins, with 20 standard types that combine in unique sequences to create biologically active molecules.
Body Protection Compound-157, a synthetic 15-amino acid peptide derived from human gastric juice with potent tissue-healing and neuroprotective properties.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONCompara BPC-157 y TB-500 para investigación de recuperación. Mecanismos, beneficios, dosificación y cuándo usar cada péptido. Compra ambos como plumas premezcladas.
COMPARISONCompara tirzepatida y semaglutida para investigación metabólica. Receptor dual vs simple, datos de eficacia, efectos secundarios y precios. Compra plumas de tirzepatida.
ENCYCLOPEDIAPentadecapéptido gástrico. Peso molecular: 1419.53 Da. Explora el mecanismo de acción, estudios clave y aplicaciones de investigación.
BUNDLEEl dúo clásico de curación para una reparación tisular acelerada
PROTOCOLProtocolo de investigación que combina los pens de péptidos BPC-157 y TB-500 para la recuperación tisular acelerada. Explore los mecanismos de curación sinérgica, los esquemas de dosificación y los hallazgos de estudios publicados.
FAQTodo sobre los sistemas de pen de péptidos. Cómo funcionan, ventajas sobre los viales y mecanismos de dosificación.
CATEGORYPlumas de péptidos de recuperación de grado de investigación. BPC-157 y TB-500 para reparación de tejidos, cicatrización de heridas e investigación de inflamación. Pureza >99%.
CATEGORYPlumas de péptidos para investigación de pérdida de peso. Tirzepatida — agonista dual GIP/GLP-1 para investigación metabólica. Plumas premezcladas, pureza >99%.
Premium pre-mixed peptide pens with next-day UK delivery. GMP manufactured, >99% purity guaranteed.
SHOP ALL PEPTIDES